phenylketonurias/obésité

Le lien est enregistré dans le presse-papiers

Choisissez le type de tri

Page 1 de 46 résultats

The Adolescent Adjustment Profile (AAP) in comparisons of patients with obesity, phenylketonuria or neurobehavioural disorders.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Psychosocial development in children with chronic disease is a key issue in paediatrics. This study investigated whether psychosocial adjustment could be reliably assessed with the 42-item Adolescent Adjustment Profile (AAP) instrument. The study mainly focused on adjustment-to-obesity measurement,

Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

BACKGROUND Little is known about the consequences of the special energy enriched diet used to treat patients with phenylketonuria (PKU) in terms of obesity and metabolic syndrome (MetSyn) development. OBJECTIVE To investigate the prevalence of overweight and obesity, and its consequences in terms of

Overweight in classical phenylketonuria children: A retrospective cohort study.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

This cohort study aimed to determine the frequency of overweight and obesity in classical phenylketonuria children and to identify the possible influence of metabolic control on the BMI of the studied patients.The study group included 63 classical

High prevalence of overweight and obesity in females with phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

The primary treatment for phenylketonuria (PKU) is a low phenylalanine diet together with an amino acid-based, phenylalanine-free formula. Thus, PKU patients tend to consume a diet enriched in carbohydrates which could predispose to obesity. Studies in the 1980s and 1990s demonstrated that

Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 ( LAT1) gene increases the risk of obesity in infants with phenylketonuria

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Purpose: Phenylketonuria (PKU) can be effectively treated with the use of a low-phenylalanine diet. However, some patients become overweight despite proper dietary treatment. We hypothesized that this phenomenon could be explained by the

Is overweight an issue in phenylketonuria?

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Dietary treatment may be associated with an increased risk of obesity in phenylketonuria (PKU). The earliest studies describe a tendency for overweight in PKU, but not all recent publications confirm this, although there are an increasing number of studies describing increased obesity in female

Effects of oral contraceptives and obesity on carrier tests for phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

[Phenylketonuria. Treatment and developmental control].

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

We evaluated annually the compliance of dietary restriction, weight, height, head circumference EEG and IQ score on 16 children with phenylketonuria comparing the children diagnosed early with those later. The compliance was good in children treated early and bad in the others. Height and head

[Phenylketonuria diagnosed during the neonatal period and breast feeding].

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

BACKGROUND Phenylketonuria (PKU) is due to of a defect in the phenylalanine hydroxylase gene (12q22-24.1) leading to hyperphenylalaninemia. Treatment consists in a low phenylalanine (Phe) diet. OBJECTIVE To evaluate the evolution of early diagnosed PKU children, receiving direct breast feeding, and

Recommendations for protein and energy intakes by patients with phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Recent reports describe poor growth in treated children with phenylketonuria (PKU). That poor growth is not a concomitant of the disorder and need not result from therapy is demonstrated by data from the U.S.A. PKU Collaborative Study and from recent data from the U.S.A. In these studies, sufficient

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

BACKGROUND In phenylketonuria, dietary treatment prevents most of the severe brain disease. However, patients have to follow a diet restricted in several natural components, what may cause decreased bone density and obesity. Exercise is known to improve both mental functioning and bone density also

Metabolic syndrome in children and adolescents with phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

OBJECTIVE This study aimed to identify markers of metabolic syndrome (MS) in patients with phenylketonuria (PKU). METHODS This was a cross-sectional study consisting of 58 PKU patients (ages of 4-15 years): 29 patients with excess weight, and 29 with normal weight. The biochemical variables assessed

Nutritional and metabolic parameters of children and adolescents with phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Considering that phenylalanine-poor diets may be monotonous and compromise the development and nutritional status of children and adolescents with phenylketonuria, the aim of this study was to evaluate the anthropometric and biochemical characteristics of children and adolescents with

Evaluation of a phenylalanine-free product for treatment of phenylketonuria.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Ten children with classic phenylketonuria (PKU) participated in a controlled study of a phenylalanine-free formula recently released in the United States (PKU-2). Control data were obtained in the clinic while the children were receiving their baseline formula. The children were given the study

Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Lifelong treatment of phenylketonuria (PKU) includes a phenylalanine (phe) restricted diet that provides sufficient phe for growth and maintenance plus phe-free amino acid formula to meet requirements for protein, energy and micronutrients. Phe tolerance (mg phe/kg body weight/day) is the amount of

Rejoignez notre
page facebook

Herbal & Natural Medicine

La base de données d'herbes médicinales la plus complète soutenue par la science

Fonctionne en 55 langues
Cures à base de plantes soutenues par la science
Reconnaissance des herbes par image
Carte GPS interactive - étiquetez les herbes sur place (à venir)
Lisez les publications scientifiques liées à votre recherche
Rechercher les herbes médicinales par leurs effets
Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées